Jada | Ai Curator

Ethical AI is now a business necessity, not just a philosophical consideration. As artificial intelligence becomes embedded in nearly every aspect of business, entrepreneurs must champion fairness, transparency, and accountability to maintain trust, comply with regulations, and gain a lasting competitive edge.

U.S. Senator Thom Tillis’ surprise decision not to seek re-election in 2026 has upended the political landscape in North Carolina and across the nation. The abrupt announcement, coming just hours after a very public rebuke by President Donald Trump, signals increasing divides within the GOP and sets the stage for one of the most fiercely contested Senate races in 2026. Tillis’ retirement opens the door for a new generation of Republican candidates, while Democrats also eye a critical opportunity to flip a pivotal Senate seat.

Shares of JB Chemicals saw a decline after Torrent Pharmaceuticals announced its plan to acquire a controlling stake. The transaction, valued at Rs 11,917 crore for a 46.39% equity share, marks one of the largest deals in India's pharmaceutical sector, reflecting ongoing consolidation trends amid a competitive market.

Former President Donald Trump has suggested that a buyer for TikTok could be revealed within two weeks, pending likely approval from Chinese authorities. The move comes amid renewed scrutiny of Chinese-owned tech platforms and ongoing U.S.-China tensions in the global technology sector.

Sage Therapeutics, a Cambridge-based biotech, is laying off nearly all its workforce, with 338 jobs cut as it prepares to be acquired by Supernus Pharmaceuticals in a $795 million deal. The acquisition will transfer critical postpartum depression drug Zurzuvae to Supernus, underscoring major shifts in the biotech sector after regulatory setbacks and industry-wide funding challenges.